Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Evotec Receives $5M Milestone Payment From Bristol Myers Squibb Following FDA IND Acceptance Under Strategic Protein Degradation Partnership

Author: Benzinga Newsdesk | November 12, 2025 02:23am

Milestone payment reflects continued progress under strategic research collaboration addressing high-need patient populations
FDA clearance of IND application triggered a US$ 5 m milestone payment to Evotec

Posted In: BMY EVO